¶ Stress Granules and RNA Granules in Neurodegeneration
Stress Granules And Rna Granules In Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Stress granules (SGs) and other RNA granules are membrane-less organelles that form in response to cellular stress. They contain translationally arrested mRNAs and associated proteins, serving as temporary storage to conserve energy during stress and promote survival. In neurodegenerative diseases, dysregulated stress granule dynamics contribute to protein aggregation, disrupted proteostasis, and neuronal death.
Understanding stress granule biology provides insights into the pathogenesis of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer's disease (AD), and Parkinson's disease (PD), where RNA granule proteins like TDP-43 and FUS are frequently found in pathological aggregates.
Triggers:
- Oxidative stress
- ER stress
- Heat shock
- UV radiation
- Viral infection
- Mitochondrial dysfunction
Initiation:
- Global translation arrest via eIF2α phosphorylation
- 43S pre-initiation complex stalling
- mRNA accumulation and aggregation
- Liquid-liquid phase separation (LLPS)
Core Components:
- G3BP1/2 (Ras-GAP SH3-domain-binding protein): Key nucleating factor
- TIA-1 (T-cell-restricted intracellular antigen-1): Promotes SG formation
- TIA1R: Alternative splicing regulator
- TTP (Tristetraprolin): mRNA decay factor
- eIF4E/eIF4G: Translation initiation factors
LLPS is the biophysical process driving SG assembly:
Mechanism:
- Multivalent protein interactions
- Low-complexity domains (LCDs)
- RNA binding promotes phase separation
- Scaffold proteins nucleate assembly
Properties:
- Droplet-like morphology
- Dynamic exchange with cytoplasm
- Reversible dissolution when stress resolves
- Age-related changes affect SG dynamics
Processing Bodies (P-bodies):
- mRNA decay machinery
- Contains decapping enzymes (DCP1/2)
- miRNA-mediated silencing
- Stationary mRNA storage
Nucleolus:
- Ribosome biogenesis
- Contains fibrillarin, nucleolin
- Stress-responsive changes
Neuronal RNA Granules:
- Transport granules for dendritic mRNAs
- Contains ZBP1, Staufen
- Local translation regulation
flowchart TD
A[Cellular Stress] --> B[eIF2α Phosphorylation] -->
B --> C[Global Translation Arrest] -->
C --> D[mRNA Accumulation] -->
D --> E[LLPS-Driven Assembly] -->
E --> F[Stress Granule Formation] -->
F --> G[Core Proteins] -->
F --> H[mRNA Storage] -->
F --> I[Peripheral Proteins] -->
G --> J[G3BP1/2] -->
G --> K[TIA-1] -->
G --> L[TDP-43)
G --> M[FUS)
I --> N[Ribosomal Proteins] -->
I --> O[Signal Transduction] -->
F --> P{Normal Resolution}
P --> Q[Stress Recovery] -->
P --> R[Prolonged Stress] -->
R --> S[Dysregulated SGs] -->
S --> T[Aggregation] -->
T --> U[TDP-43/FUS Inclusions] -->
U --> V[Neuronal Dysfunction]
TDP-43 Pathology:
- TDP-43 is a major component of ALS inclusions
- Mutations in TARDBP cause familial ALS
- TDP-43 sequestered in stress granules
FUS Pathology:
- FUS mutations cause familial ALS
- FUS localizes to stress granules
- Mutant FUS disrupts SG dynamics
Mechanisms:
- Impaired SG dissolution
- Prolonged SG persistence
- Sequestration of translation machinery
- Disrupted RNA metabolism
TDP-43-FTD:
- TDP-43 pathology in 50% of FTD cases
- Similar to ALS mechanisms
- Mutations in GRN (progranulin) affect SG dynamics
FUS-FTD:
- FUS inclusions in certain FTD subtypes
- Mutations affect SG localization
- Dysregulated RNA metabolism
Stress Granule Involvement:
- TIA-1 in AD brain
- SG proteins in tau inclusions
- eIF2α phosphorylation increased
Consequences:
- Impaired protein synthesis
- Synaptic dysfunction
- Enhanced tau pathology
- Cellular stress response failure
Alpha-Synuclein and SG Interaction:
- α-Synuclein affects SG formation
- G3BP1 in Lewy bodies
- Stress granule markers in PD brain
Mechanisms:
- Cellular stress exacerbated
- Impaired stress response
- Enhanced protein aggregation
| Agent |
Mechanism |
Status |
Disease |
| ISRIB |
eIF2α antagonist |
Research |
ALS/AD |
| Guanabenz |
eIF2α phosphatase inhibitor |
Research |
ALS |
| Sephin1 |
GADD34 inhibitor |
Research |
Various |
| Agent |
Mechanism |
Status |
Disease |
| LLPS modulators |
Alter phase behavior |
Research |
ALS |
| Small molecule disaggregases |
Disrupt aggregates |
Preclinical |
ALS/FTD |
| Agent |
Mechanism |
Status |
Disease |
| ASO therapies |
Reduce pathogenic proteins |
Clinical |
ALS |
| Autophagy enhancers |
Clear persistent SGs |
Research |
Multiple |
- TDP-43 pathology is present in 97% of ALS cases and 50% of FTD cases
- Stress granule persistence is a hallmark of ALS/FTD
- FUS mutations affect nuclear import and SG localization
- LLPS is now recognized as central to neurodegenerative protein aggregation
- G3BP1 is essential for stress granule formation
- eIF2α phosphorylation is a therapeutic target
- Persistent stress granules may seed pathological inclusions
The study of Stress Granules And Rna Granules In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Wolozin B, Ivanov P. (2019). Stress granules and neurodegeneration. Nat Rev Neurosci. 20(11):649-666.
- Buchan JR, Parker R. (2009). Eukaryotic stress granules: the ins and outs of translation. Mol Cell. 36(6):932-941.
- Dormann D, et al. (2010). ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 29(16):2841-2857.
- Nonaka T, et al. (2018). Prion-like properties of stress granules in neurodegenerative diseases. Brain Res Bull. 139:140-146.
- Bentmann E, et al. (2012). Requirements for stress granule recruitment of fused in sarcoma (FUS) and TDP-43. J Cell Sci. 125(Pt 18):4441-4451.
- Vanderweyde T, et al. (2016). Contrasting pathology of stress granule proteins in Alzheimer's disease and ALS. Mol Cell Neurosci. 76:41-48.
- Ash PE, et al. (2021). Stress granules in neurodegeneration - lessons learned from TDP-43 and FUS. FEBS J. 288(19):5576-5594.
- Boeynaems S, et al. (2018). Phase separation and aggregation of proteins in neurodegeneration: fact or fiction. Trends Neurosci. 41(12):823-835.
- Martinez FJ, et al. (2016). Protein homeostasis and ALS. Prog Mol Biol Transl Sci. 139:15-33.
- Li YR, et al. (2013). Stress granules: the soup of neurodegeneration. Transl Neurodegener. 2(1):7.
🔴 Low Confidence
| Dimension |
Score |
| Supporting Studies |
10 references |
| Replication |
0% |
| Effect Sizes |
25% |
| Contradicting Evidence |
0% |
| Mechanistic Completeness |
50% |
Overall Confidence: 31%